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Studies in nonhuman primates indicate that one pathophysiologic consequence of ozone exposure is chronic bronchiolitis in terminal bronchioles.
Modeling dosimetry suggests that a similar phenomenon is possible in humans. These findings may constitute an important analogy to the respira-
tory bronchiolitis that is associated with tobacco smoking in young adults. This analogy could form the basis for future research related to chronic
respiratory health effects of ozone. The smoking data are reviewed and several research strategies are proposed that will be developed more fully in
subsequent articles in this volume. - Environ Health Perspect 101(Suppl 4):217-218 (1993).
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Laboratory studies in animals and con-
trolled exposure studies in humans consis-
tently have demonstrated an upper and
lower respiratory tract inflammatory
response to ozone exposure. The hallmark
of this response is the polymorphonuclear
leukocyte, but other markers of activated
inflammatory and repair responses have
been observed. These phenomena proba-
bly are accompanied by increased lung per-
meability. Animal studies of the effect of
ozone exposure, including most particu-
larly those on nonhuman primates (1),
suggest that one pathophysiologic conse-
quence of the inflammatory response to
prolonged or repetitive ozone exposure is a
chronic bronchiolitis in terminal bronchi-
oles. This is consistent with modeling
dosimetry calculations that indicate that
this zone will be the location of maximal
deposition in the human (2). The animal
database has shown that primates are more
sensitive to ozone exposure than rodents
and that morphological changes induced
with long-term or repetitive exposures are
not reversible.
A report by Sherwin and Richters (3) of
studies of the autopsy lungs of 107 youths
between 14 and 25 years who died ofnon-
respiratory causes in Los Angeles indicates
that a severe chronic bronchiolitis was pre-
sent in the same region ofthe lung in one-
third of the cases. Although quantitative
morphometry on the specimens and control
data from other, less polluted cities are not
This manuscript was prepared as part of the Environ-
mental Epidemiology Planning Project of the Health
Effects Institute, September 1990-September 1992.
yet available, these preliminary observations
offer impetus to the search for a relation-
ship between respiratory bronchiolitis and
ozone exposure.
The above observations suggest that
there may be an important analogy to the
respiratory bronchiolitis associated with
tobacco smoking in young adults (4).
Studies ofthe respiratory bronchiolitis that
has been associated with cigarette smoking
are reviewed briefly to illustrate the types
and limitations ofdata thatwill be required
to establish a similar link in relationship to
chronic ozone exposure.
Respiratory bronchiolitis of variable
sever-ity in smokers was first described by
Niewohner and his colleagues (4). A
recent comparison ofsmall airway inflam-
mation in 42 smokers and 13 nonsmokers
in Vermont (5), in which the bronchiolar
changes were evaluated by quantitative
morphometry, indicated that in the 20- to
30-year-old subjects, the mean score for
bronchiolar wall inflammation was about
three times larger in smokers than nonsmok-
ers. This confirms earlier work indicating
the samephenomenon.
The physiological correlates [tests of
small airway function) of these changes
have been noted in many surveys (more
than 70 in 1989 (6,7)] of smokers and
nonsmokers. These findings can be sum-
marized as tests of small airway function
that indicate differences between smokers
and nonsmokers (even in teenagers) in the
following parameters (1): a) single breath
nitrogen slope, b) dosing volume, c) mid-
expiratory flow rates, d) change ofdynamic
compliance with respiratory frequency, e)
differences in regional ventilation in the
lung measured with radioactive xenon, and
f) changes in alveolar-arterial oxygen ten-
sion differences with posture. Ofparticular
importance is the fact that all of these dif-
ferences have been documented to occur
when the FEV1 is still normal or nearly so
(95% ofpredicted).
Because it is not dear yet whether ciga-
rette smoking induces a premature loss of
lung recoil (6), the elevation ofresidual vol-
ume (that could produce the above patho-
physiologic changes) found in 30-year-old
smokers before FEV1 has been reduced
might be due to loss ofrecoil and/or to the
small airway lesions noted above. It has
been reported that in smokers small airway
tests are not predictive oflater FEVy decline
(8). However, the observation thatsmoking
cessation is followed by small, but signifi-
cant, functional improvement (9,10) sup-
ports the view that reversible respiratory
bronchiolitis maybepresent.
Given the acute inflammatory responses
that have been observed with ozone expo-
sure, the recent study by Richards et al.
(11) provides an important bridge between
the smoking data and possible effects of
ozone exposure. These investigators
observed that the fall in midexpiratory flow
rates in smokers under the age of 30 was
accompanied by increasing levels of neu-
trophil activation (measured by chemilumi-
nescence). In 60 healthy young smokers
(mean age 28 years), the flow rate tests of
small airway function were performed in a
laboratory setting. The standard error of
the mean of the tests varied between 1.1
and 4.9. The mean FEF25-75, as a percent
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of predicted, was 121.9% in the group
with the least affected function and 71.3%
in the worst group. The mean FEV1 was
105.5% of predicted in the former and
94.9% of predicted in the latter group.
Although the midexpiratory flow rate mea-
surements have a higher coefficient ofvari-
ation than the FEV1, it is clear from this
study that they not only possess much
more discrimination than the FEV1 in rela-
tion to the early changes in smokers (which
morphological studies have indicated are
changes of bronchiolitis), but they also
have a sufficiently low coefficient ofvaria-
tion to be used for this purpose, at least in
the laboratory setting.
There is no evidence that the early
appearance of respiratory bronchiolitis in
smokers is related to the later development
ofemphysema. Perhaps this is not surpris-
ing in view ofthe known complexity ofthe
steps that lead to lung destruction. For this
reason, some physicians have dismissed too
readily the considerable body of evidence
indicating that smoking induces respiratory
bronchiolitis. There is subsequent evidence
from studies of occupationally exposed
cohorts and individual cases (6) that mid-
flow rates predominately reflect small airway
changes; this is true in allergic alveolitis,
exposures to irritant gases, and dust expo-
sures, including asbestos. Sarcoidosis and
postviral bronchiolitis provide the best
examples of nonoccupational small airway
involvement (6).
Two approaches address the question of
whether oxidant exposure is associated with
respiratory bronchiolitis. The study of
Sherwin and Richters (3) suggests that the
use of autopsied lungs would be ofvalue,
and this approach is developed in detail by
Lippmann in this volume (12).
The studyofRichards et al. (11) suggests
that biological markers of inflammation, in
conjunction with the appropriate measures
of small airways' functions, would offer
another fruitful approach to this problem.
Devlin's paper in this volume (13) provides
details on markers of ozone exposure, and
Hatch and Thomas' paper (14) provides
general guidelines for the utility and applica-
tion ofbiological markers in epidemiologic
studies. Moreover, the issues ofsite selection
for studies; the requirements for valid, retro-
spective exposure assessment; and the selec-
tion ofmetrics forozone exposure are detailed
by Lippmann. Studies that employ biologi-
cal markers ofresponse to ozone in conjunc-
tion with appropriate measures of lung
function would be important adjuncts to
data derived from autopsy studies and stud-
ies derived from controlled exposures to
ozone (13,15) that seek to define more
clearly the biochemical and cellular responses
ofthe lungto ozone exposure. e
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